Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot

被引:29
|
作者
Bokma, Jouke P. [1 ]
Geva, Tal [2 ,3 ]
Sleeper, Lynn A. [2 ,3 ]
Lee, Ji Hae [2 ,3 ]
Lu, Minmin [2 ,3 ]
Sompolinsky, Tehila [2 ,3 ]
Babu-Narayan, Sonya V. [4 ]
Wald, Rachel M. [5 ]
Mulder, Barbara J. M. [1 ]
Valente, Anne Marie [2 ,3 ]
机构
[1] Amsterdam Univ Med Ctr Amsterdam, Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands
[2] Boston Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA USA
[4] Royal Brompton Hosp, Dept Adult Congenital Heart Dis, London, England
[5] Toronto Congenital Cardiac Ctr Adults, Peter Munk Cardiac Ctr, Toronto, ON, Canada
基金
芬兰科学院; 美国国家卫生研究院; 加拿大健康研究院;
关键词
cardiovascular magnetic resonance imaging; congenital heart disease; pulmonary valve replacement; tetralogy of Fallot; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGENITAL HEART-DISEASE; CLINICAL-OUTCOMES; IMPACT; ADULTS; RISK; REGURGITATION; SOCIETY;
D O I
10.1016/j.jacc.2023.02.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The impact of pulmonary valve replacement (PVR) on major adverse clinical outcomes in patients with repaired tetralogy of Fallot (rTOF) is unknown.OBJECTIVES The purpose of this study was to determine whether PVR is associated with improved survival and freedom from sustained ventricular tachycardia (VT) in rTOF.METHODS A PVR propensity score was created to adjust for baseline differences between PVR and non-PVR patients enrolled in INDICATOR (International Multicenter TOF Registry). The primary outcome was time to the earliest occurrence of death or sustained VT. PVR and non-PVR patients were matched 1:1 on PVR propensity score (matched cohort) and in the full cohort, modeling was performed with propensity score as a covariate adjustment.RESULTS Among 1,143 patients with rTOF (age 27 & PLUSMN; 14 years, 47% PVR, follow-up 8.3 & PLUSMN; 5.2 years), the primary outcome occurred in 82. The adjusted HR for the primary outcome for PVR vs no-PVR (matched cohort n = 524) was 0.41 (95% CI: 0.21-0.81; multivariable model P = 0.010). Full cohort analysis revealed similar results. Subgroup analysis suggested beneficial effects in patients with advanced right ventricular (RV) dilatation (interaction P = 0.046; full cohort). In patients with RV end-systolic volume index >80 mL/m2, PVR was associated with a lower primary outcome risk (HR: 0.32; 95% CI: 0.16-0.62; P < 0.001). There was no association between PVR and the primary outcome in patients with RV end-systolic volume index #80 mL/m2 (HR: 0.86; 95% CI: 0.38-1.92; P = 0.70). CONCLUSIONS Compared with rTOF patients who did not receive PVR, propensity score-matched individuals receiving PVR had lower risk of a composite endpoint of death or sustained VT. (J Am Coll Cardiol 2023;81:2075-2085) & COPY; 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:2075 / 2085
页数:11
相关论文
共 50 条
  • [1] Comment on: "Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot"
    Hudaib, Muhammad
    Malik, Hurais
    Rabbani, Samra
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (10)
  • [2] Pulmonary valve replacement after repaired Tetralogy of Fallot
    Hideki Tatewaki
    Akira Shiose
    [J]. General Thoracic and Cardiovascular Surgery, 2018, 66 : 509 - 515
  • [3] Pulmonary valve replacement after repaired Tetralogy of Fallot
    Tatewaki, Hideki
    Shiose, Akira
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2018, 66 (09) : 509 - 515
  • [4] Outcomes after pulmonary valve replacement in patients with repaired tetralogy of Fallot: end of a success story?
    Latus, Heiner
    Tutarel, Oktay
    [J]. HEART, 2018, 104 (09) : 717 - 718
  • [5] Tricuspid Valve Repair at Pulmonary Valve Replacement in Repaired Tetralogy of Fallot
    Jooncheol Min
    Jae Gun Kwak
    Sungkyu Cho
    Eung Re Kim
    Jae Hong Lim
    Chang-Ha Lee
    Woong-Han Kim
    [J]. Pediatric Cardiology, 2022, 43 : 74 - 81
  • [6] Repair of tricuspid valve with pulmonary valve replacement in repaired tetralogy of fallot
    Kim, Susan Taejung
    Song, Jinyoung
    Kim, Yi-Seul
    Huh, June
    Kang, I-Seok
    Yang, Ji-Hyuk
    Jun, Tae-Gook
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (03) : 148 - 152
  • [7] Tricuspid Valve Repair at Pulmonary Valve Replacement in Repaired Tetralogy of Fallot
    Min, Jooncheol
    Kwak, Jae Gun
    Cho, Sungkyu
    Kim, Eung Re
    Lim, Jae Hong
    Lee, Chang-Ha
    Kim, Woong-Han
    [J]. PEDIATRIC CARDIOLOGY, 2022, 43 (01) : 74 - 81
  • [8] Relation of Right Ventricular Dilation After Pulmonary Valve Replacement to Outcomes in Patients With Repaired Tetralogy of Fallot
    Pastor, Tony A.
    Geva, Tal
    Lu, Minmin
    Duarte, Valeria E.
    Drakeley, Sheila
    Sleeper, Lynn A.
    Valente, Anne Marie
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (06): : 977 - 981
  • [9] Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot
    Lee, Cheul
    Choi, Eun Seok
    Lee, Chang-Ha
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (02) : 246 - 252
  • [10] Pulmonary valve replacement in repaired tetralogy of Fallot: Determinants of early postoperative adverse outcomes
    Dos, Laura
    Dadashev, Alexander
    Tanous, David
    Ferreira-Gonzalez, Ignacio J.
    Haberer, Kim
    Siu, Samuel C.
    Van Arsdell, Glen S.
    Oechslin, Erwin N.
    Williams, William G.
    Silversides, Candice K.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (03): : 553 - 559